André Ulmann founded HRA Pharma Development SARL and Laboratoire HRA-Pharma SA.
He holds the position of Chief Executive Officer of Cemag Consulting and Chief Executive Officer & Director at Advicenne SA. Dr. Ulmann is also on the board of HRA Pharma Development SARL (former Director).
In the past Dr. Ulmann held the position of Chairman of Onxeo SA and Principal at Roussel Uclaf SA.
André Ulmann received a doctorate from the University of Paris Jussieu.